HIV Citation List: August 16 - August 29, 2013
PubMed citations
1. The in Vitro Cross-resistance Profile of the Nucleoside Reverse Transcriptase Inhibitor (NRTI) BMS-986001 against Known NRTI Resistance Mutations. Li, Z., B. Terry, W. Olds, T. Protack, C. Deminie, B. Minassian, B. Nowicka-Sans, Y. Sun, I. Dicker, C. Hwang, M. Lataillade, G.J. Hanna, and M. Krystal. Antimicrobial Agents and Chemotherapy, 2013. [Epub ahead of print]. PMID[23979732].
[PubMed]. HIV_0816-082913.
2. Inhibition of HIV-1 Enzymes, Antioxidant and Anti-inflammatory Activities of Plectranthus barbatus. Kapewangolo, P., A.A. Hussein, and D. Meyer. Journal of Ethnopharmacology, 2013. 149(1): p. 184-190. PMID[23811046].
[PubMed]. HIV_0816-082913.
3. In Vitro and in Vivo Activities of AIC292, a Novel HIV-1 Nonnucleoside Reverse Transcriptase Inhibitor. Wildum, S., D. Paulsen, K. Thede, H. Ruebsamen-Schaeff, and H. Zimmermann. Antimicrobial Agents and Chemotherapy, 2013. [Epub ahead of print]. PMID[23959304].
[PubMed]. HIV_0816-082913.
4. Evaluating the Potential of IL-27 as a Novel Therapeutic Agent in HIV-1 Infection. Swaminathan, S., L. Dai, H.C. Lane, and T. Imamichi. Cytokine Growth Factor Reviews, 2013. [Epub ahead of print]. PMID[23962745].
[PubMed]. HIV_0816-082913.
5. Discovery of HIV-1 Integrase Inhibitors: Pharmacophore Mapping, Virtual Screening, Molecular Docking, Synthesis and Biological Evaluation. Bhatt, H., P. Patel, and C. Pannecouque. Chemical Biology and Drug Design, 2013. [Epub ahead of print]. PMID[23957390].
[PubMed]. HIV_0816-082913.
ISI Web of Knowledge Citations
6. Chemical Constituents from the Branches and Leaves of Pyrus pashia Buch.-Ham. Ex D. Don. Zhao, M., L. Cai, J.M. He, T.P. Yin, Y.C. Sui, M.T. Luo, and Z.T. Ding. Chinese Journal of Organic Chemistry, 2013. 33(6): p. 1284-1290. ISI[000322053600014].
[WOS]. HIV_0816-082913.
7. Epitope Mapping of M36, a Human Antibody Domain with Potent and Broad HIV-1 Inhibitory Activity. Wan, C., J.P. Sun, W.Z. Chen, X.H. Yuan, H.H. Chong, P. Prabakaran, D.S. Dimitrov, and Y.X. He. PloS One, 2013. 8(6). ISI[000320755400152].
[WOS]. HIV_0816-082913.
8. Peptide and Protein-based Inhibitors of HIV-1 Co-receptors. von Recum, H.A. and J.K. Pokorski. Experimental Biology and Medicine, 2013. 238(5): p. 442-449. ISI[000321758200001].
[WOS]. HIV_0816-082913.
9. Syntheses and in Vitro Biological Screening of 1-Aryl-10H-[1,2,4]triazolo[3',4':3,4][1,2,4]triazino[5,6-b]indoles. Upadhyay, K., A. Manvar, R. Loddo, P. La Colla, V. Virsodiya, J. Trivedi, R. Chaniyara, and A. Shah. Medicinal Chemistry Research, 2013. 22(8): p. 3675-3686. ISI[000320673200013].
[WOS]. HIV_0816-082913.
10. Pseudomonas DING Proteins as Human Transcriptional Regulators and HIV-1 Antagonists. Suh, A., V. Le Douce, O. Rohr, C. Schwartz, and K. Scott. Virology Journal, 2013. 10. ISI[000322130500001].
[WOS]. HIV_0816-082913.
11. A One Pot Microwave Assisted Synthesis of 3-Acyl-2,4-dihydroxyquinoline Followed by Synthesis of 7-Methyldibenzo[c,f][2,7]naphthyridin-6(5H)-ones Via Three Routes. Pitchai, P., C. Uvarani, R.M. Gengan, and P.S. Mohan. Indian Journal of Chemistry Section B-Organic Chemistry Including Medicinal Chemistry, 2013. 52(6): p. 776-786. ISI[000320827400002].
[WOS]. HIV_0816-082913.
12. Comparative in Vitro Functional Analysis of Synthetic Defensins and Their Corresponding Peptide Variants against HIV-1NL4.3, E. coli, S. aureus and P. aeruginosa. Mohan, T., D. Mitra, and D.N. Rao. International Journal of Peptide Research and Therapeutics, 2013. 19(3): p. 245-255. ISI[000322529300010].
[WOS]. HIV_0816-082913.
13. Anti-HIV-1 Activity, Protease Inhibition and Safety Profile of Extracts Prepared from Rhus parviflora. Modi, M., Nutan, B. Pancholi, S. Kulshrestha, A.K.S. Rawat, S. Malhotra, and S.K. Gupta. Bmc Complementary and Alternative Medicine, 2013. 13. ISI[000321980000001].
[WOS]. HIV_0816-082913.
14. A Modified Zinc acetate Gel, a Potential Nonantiretroviral Microbicide, Is Safe and Effective against Simian-Human Immunodeficiency Virus and Herpes Simplex Virus 2 Infection in Vivo. Kenney, J., A. Rodriguez, L. Kizima, S. Seidor, R. Menon, N. Jean-Pierre, P. Pugach, K. Levendosky, N. Derby, A. Gettie, J. Blanchard, M. Piatak, J.D. Lifson, G. Paglini, T.M. Zydowsky, M. Robbiani, and J.A.F. Romero. Antimicrobial Agents and Chemotherapy, 2013. 57(8): p. 4001-4009. ISI[000321761800070].
[WOS]. HIV_0816-082913.
15. Novel PCU Cage Diol Peptides as Potential Targets against Wild-type CSA HIV-1 Protease: Synthesis, Biological Screening and Molecular Modeling Studies. Karpoormath, R., Y. Sayed, T. Govender, H.G. Kruger, M.E.S. Soliman, and G.E.M. Maguire. Medicinal Chemistry Research, 2013. 22(8): p. 3918-3933. ISI[000320673200038].
[WOS]. HIV_0816-082913.
16. 4-Substituted 2-Hydroxyisoquinoline-1,3(2H,4H)-diones as a Novel Class of HIV-1 Integrase Inhibitors. Billamboz, M., V. Suchaud, F. Bailly, C. Lion, J. Demeulemeester, C. Calmels, M.L. Andreola, F. Christ, Z. Debyser, and P. Cotelle. ACS Medicinal Chemistry Letters, 2013. 4(7): p. 41-46. ISI[000321883800010].
[WOS]. HIV_0816-082913.